QUOTE
Merck & Co Inc (MRK)
$
38.78
 $0.10 (0.26%) Jan 26
|
P.O. Box 100 One Merck Drive
,
Whitehouse Station,
NJ
08889
,
USA
+1-908-423-1000
http://www.merck.com |
|
|
| PRICES |
| Open |
Volume |
| 38.84 |
12.39M |
| High |
Low |
| 38.95 |
38.54 |
|
| VALUATIONS |
| Mkt Cap |
Avg Volume |
| 119439 |
4.96M |
| 52wk High |
52wk Low |
| 39.26 |
29.81 |
|
| RATIOS |
| P/E |
EPS |
| n/a |
n/a |
| BV |
P/BV |
| 18.05 |
2.15 |
|
| STOCKHOLDERS |
| Dividend |
Yield |
| 1.56 |
4.02% |
| Shares |
Inst Owner |
| 3079.92 |
|
|
|
|
|
PERFORMANCE
You need to upgrade your Flash Player
|
|
ANNUAL EARNINGS
You need to upgrade your Flash Player
|
|
QUARTERLY EARNINGS (EPS)
You need to upgrade your Flash Player
|
|
SUMMARIES CALENDARS REPORTS
|
|
| Financial Summary (In millions of USD)
|
| |
2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 |
| Income statement |
| Total Revenue |
$22,485.90 | $22,972.80 | $22,011.90 | $22,636 | $24,197.70 | $23,850.30 | $27,428.30 | $45,987 |
| Operating Income |
$9,051.60 | $8,002.80 | $7,363.90 | $6,221.40 | $3,370.70 | $9,807.80 | $15,291.80 | $1,653 |
| Net Income |
$6,830.90 | $5,830.10 | $4,631.30 | $4,433.80 | $3,275.40 | $7,808.40 | $12,901.30 | $861 |
| Balance Sheet |
| Total Assets |
$40,587.50 | $42,572.80 | $44,845.80 | $44,569.80 | $48,350.70 | $47,195.70 | $47,195.70 | $112,089.70 |
| Total Equity |
$15,576.40 | $17,288.20 | $17,977.70 | $17,559.70 | $18,184.70 | $18,758.30 | $18,758.30 | $59,058 |
| Total Liabilities |
$25,011.10 | $25,284.60 | $26,868.10 | $27,010.10 | $30,166 | $28,437.40 | $28,437.40 | $53,031.70 |
| Cash Flow |
| Operating |
$9,893.60 | $8,799.10 | $7,608.50 | $6,765.20 | $6,999.20 | $6,571.70 | $6,571.70 | $3,392 |
| Investing |
$-4,263.40 | $-1,638.10 | $2,267.20 | $-4,883.70 | $-2,810 | $-1,834.40 | $-1,834.40 | $3,156 |
| Financing |
$-6,827.90 | $-5,591.40 | $-3,040.40 | $-5,604.20 | $-4,866.10 | $-5,522.50 | $-5,522.50 | $-1,638.30 |
| Net Cash Change |
$-1,042 | $1,677.80 | $6,706.50 | $-3,670.60 | $-578.60 | $-967.80 | $-967.80 | $4,943.10 |
|
Earning Call Calender
|
| 2010 | 2009 |
2008 |
2007 |
2006 |
16 February 2010
04 May 2010
30 July 2010
29 October 2010
|
03 February 2009
21 April 2009
21 July 2009
22 October 2009
|
30 January 2008
21 April 2008
21 July 2008
22 October 2008
|
19 April 2007
13 June 2007
23 July 2007
22 October 2007
|
31 January 2006
20 April 2006
24 July 2006
20 October 2006
| |
|
|
|
Management
|
|
Executive |
Title |
|
Richard T. Clark |
Chairman of the Board, President, Chief Executive Officer | |
|
Bruce N. Kuhlik |
Executive Vice President and General Counsel |
|
Peter S. Kim |
Executive Vice President and President, Merck Research Laboratories |
|
Peter N. Kellogg |
Executive Vice President and Chief Financial Officer |
|
Mirian Graddick-Weir |
Executive Vice President, Human Resources |
|
Kenneth C. Frazier |
Executive Vice President and President, Global Human Health |
|
Willie A. Deese |
Executive Vice President and President, Merck Manufacturing Division |
|
David W. Anstice |
Executive Vice President, Strategy Initiatives |
|
J. Chris Scalet |
Executive Vice President, Global Services, and Chief Information Officer |
|
|
|
